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11. Introduction
Two common problems in clinical trials are noncompliance and missing outcome data.
Noncompliance occurs when some subjects fail to comply with their assigned treatments;
missing data occurs when study investigators cannot collect outcome information on some
subjects. Ignoring the noncompliance or missing data may result in biased estimates of
causal eﬀects. Moreover, the assumed mechanism of missing-data also has an impact on the
estimated causal eﬀects. Many methods have been developed for handling either missing
data or noncompliance, but researchers have only recently started to develop methods for
handling both missing outcome data and noncompliance in the same study (Frangakis and
Rubin, 1999; Zhou and Li, 2006; Yau and Little, 2001; O’Malley and Normand, 2005).
Frangakis and Rubin (1999) proposed a moment estimator for the complier average causal
eﬀect (CACE) parameter under the binary compliance status and latent ignorable (LI)
missing outcome assumption. The LI assumption means the missing data mechanism has
no residual dependence with the outcome, given the observed data and latent compliance
class. Under the same LI assumption, Zhou and Li (2006) derived maximum likelihood
(ML) estimates as well as moment estimates of the CACE when the compliance status is a
discrete variable with three categories and when the outcome variable is binary. O’Malley
and Normand (2005) gave the moment and ML estimators of the CACE for a continuous
outcome variable.
The above mentioned methods may yield biased estimators of the CACE if the missing
data mechanism is a diﬀerent type of the non-ignorable missing mechanism from latent
ignorability. The mechanism of missing outcome Y may depend on missing values of Y . For
example, some subjects may drop out of a study because of a patient’s declining health
condition, which is related to Y given the observed data and latent compliance class. As
a motivating example, consider a study on the eﬀectiveness of inﬂuenza vaccine eﬃcacy
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in reducing morbidity in high-risk adults (McDonald et al., 1992). This study began in
1978 and lasted for three years. There were about two thousand patients enrolled in the
study. Physicians were randomly assigned to the treatment group of the control group at
the beginning of the study. The physicians assigned to the treatment group would encourage
their eligible patients to get a ﬂu shot. But the patients themselves decided whether or not
to take ﬂu shots. One of the main outcomes in the study was the ﬂu-related hospitalization.
Some patients’ outcomes were not observed, and the reason for missing outcomes may depend
on the missing values. For example, some subjects were missing their outcomes because they
had ﬂu but went to diﬀerent hospitals than the study hospital, and as a result their outcomes
were not recorded. Or, some patients were missing their outcomes because the reason for their
hospitalizations was unknown. When the missing data mechanism depends on the outcome,
we deﬁne this situation as completely non-ignorable (CN). The LI missing data mechanism
assumed that subjects dropped out because of subjects’ latent compliance statuses.
Analysis of CN missing data is more diﬃcult than analysis of LI data. One major diﬃculty
under the CN missing data mechanism is the issue of parameter identiﬁability. Here we
say that a parametric model Pθ is identiﬁable if there is a unique value of the parameter
vector θ that can generate a given observed distribution Fθ, that is if Fθ = Fθ′ , then
θ = θ′. When the missing-data mechanism is non-ignorable, some of parameters may not
be identiﬁable even if data provide enough degrees of freedom (Little and Rubin, 2004).
Several authors have proposed methods for dealing with CN. For example, Brown (1990)
developed an estimation method for missing normal outcome variables in longitudinal studies
under the CN missing mechanism. Robins and Rotnitzky (2004) discussed the parameter
identiﬁability in randomized trials with non-compliance. Vansteelandt and Goetghebeur
(2005) discussed the parameter identiﬁability in randomized trials with non-compliance and
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3missing data. However, no methods are available for dealing with the CN missing mechanism
and noncompliance in the same study.
In this paper we ﬁll the gap by ﬁrst studying identiﬁability of the model parameters
under the CN assumption. We show that the parameters are identiﬁable under two diﬀerent
conditions. The ﬁrst condition assumes that the missing data mechanism depends only on
the missing outcome variable. If this assumption does not hold, the parameters are not
identiﬁable. However, we can show that the parameters are also identiﬁable if we can ﬁnd
an observed discrete covariate X before the treatment assignment, which associated with Y
in each subpopulation of the compliance and treatment level. Then we derive both moment
and ML estimators.
The paper is organized as follows. We describe notation and assumptions in Section 2. In
Section 3, we give the theoretical results on identiﬁability of the parameters. In Section 4, we
conduct simulation studies to assess the ﬁnite-sample properties of the derived estimators
and sensitivity of the proposed estimators to the departure from the assumed conditions.
Then we illustrate the application of the proposed methods in a real study. We give some
concluding remarks in Section 5. The proofs of theorems are presented in Appendix.
2. Notation and Assumptions
For the sake of notational simplicity, we suppress the index i, which represents the ith
patient. Let Z represent the randomized treatment assignment (1 = new, 0 = control) and
let ξ = P (Z = 1). Let the binary variable D denote which treatment the patient receives
(1 =new treatment received, 0 =control received). Let D(Z) represent which treatment
received if the patient’s physician is assigned to the treatment Z, and Y be a binary outcome
variable. Y = 0 if the patient goes to the hospital due to the ﬂu and Y = 1 otherwise. R is
the binary response indicator of Y , that is, R = 1 if Y is observed and R = 0 if Y is missing.
We deﬁne Y {Z,D(Z)} or Y (Z) as the potential outcome of the patient if the patient is
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assigned the treatment Z. R(Z) is the potential binary response indicator of a patient if the
patient is assigned to the treatment Z. In our notation, Z, R, D, and Y are observed data
of a patient, and D(Z), Y (Z), and R(Z) are potential outcomes of a patient.
Following Imbens and Rubin (1997), we let U be the compliance status of a patient, deﬁned
as follows:
U =
⎧⎪⎪⎪⎪⎪⎪⎪⎪⎨
⎪⎪⎪⎪⎪⎪⎪⎪⎩
c, if D(0) = 0 and D(1) = 1
n, if D(0) = 0 and D(1) = 0
a, if D(0) = 1 and D(1) = 1
d, if D(0) = 1 and D(1) = 0,
where c, n, a and d represent complier, never-taker, always-taker and deﬁer, respectively. Here
U is an unobserved variable, representing compliance behavioral patterns of the patient. Let
ωu = P (U = u). For simplicity, we also denote ρyzu = P (R = 1|Y = y, Z = z, U = u)
and θyzu = P (Y = y|Z = z, U = u). As in Imbens and Rubin (1997) and Frangakis and
Rubin (1999), in this paper we consider CACE as the parameter of interest, deﬁned as
CACE = E{Y (1)− Y (0) | U = c}.
Since the joint distribution of the potential outcomes Y (z), R(z) and U conditional on
Z = z can be expressed by parameters ωu, ρyzu and θyzu, causal eﬀects are identiﬁable if we
can show these parameters are identiﬁable. Next, we will give the necessary assumptions to
make these parameters identiﬁable under the CN missing mechanism.
Assumption 1: Stable unit treatment value assumption (SUTVA) (Rubin, 1978; Angrist
et al., 1996; Imbens and Rubin, 1997).
SUTVA implies that potential outcomes do not depend on the treatment status of other
individuals.
Assumption 2: Randomization: Z is randomized.
http://biostats.bepress.com/uwbiostat/paper317
5We can express the CACE as CACE = θ11c − θ10c under the randomization assumption.
Assumption 3: Monotonicity: Di(1) ≥ Di(0) for all subjects i, which implies there are
no deﬁers.
Assumption 4: Exclusion restrictions (Angrist et al., 1996): P{Yi(1)|Ui = n} = P{Yi(0)|Ui =
n}, and P{Yi(1)|Ui = a} = P{Yi(0)|Ui = a}.
The exclusion restriction implies P (Yi|Zi = 1, Ui = n) = P (Yi|Zi = 0, Ui = n), and P (Yi|Zi =
1, Ui = a) = P (Yi|Zi = 0, Ui = a), that is θ11n = θ10n and θ11a = θ10a. In some studies, such
as double blinding, exclusion restrictions are reasonable.
Assumption 5: Compound exclusion restrictions (Frangakis and Rubin, 1999): P{Yi(1), Ri(1)|Ui =
n} = P{Yi(0), Ri(0)|Ui = n}, and P{Yi(1), Ri(1)|Ui = a} = P{Yi(0), Ri(0)|Ui = a}.
Assumption 5 is stronger than Assumption 4. Besides having the same implications as
Assumption 4, Assumption 5 also implies P (Ri|Zi = 1, Ui = n) = P (Ri|Zi = 0, Ui = n)
and P (Ri|Zi = 1, Ui = a) = P (Ri|Zi = 0, Ui = a). Assumption 4 instead of Assumption
5 is required in our Theorems 1 and 2 where the missing-data mechanism doesn’t depend
on latent compliance status variable U (Assumptions 6 and 7). Assumption 5 instead of
4 is required in Theorems 3 where the missing-data mechanism depends on both missing
outcomes and U (Assumption 8).
3. Identiﬁability and Estimation
In this section, we discuss additional conditions needed to identify the causal parameters
under the CN assumption, and then propose moment and ML estimators of causal eﬀects.
Intuition behind how identiﬁcation of parameters is achieved is related to the idea of in-
strumental variables. As we know, if there are no missing outcomes, causal parameters are
identiﬁable under the standard assumptions 1 to 4 of an instrumental variable, as shown
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in Angrist, Imbens, and Rubin (1996). When the missing data mechanism depends only on
outcomes, under the assumptions 1 to 4, as well as the assumption 6, (U,Z) can be considered
as an instrumental variable, and causal parameters are still identiﬁable. In Section 3.1, we
consider a missing-data mechanism model in which the mechanism of missing outcome Y
depends only on the outcome Y itself; that is, only the outcome Y has an eﬀect on R. Under
this assumption we provide a suﬃcient condition on parameter identiﬁability in Theorem 1.
Without any other assumptions on the missing data mechanism, only this model and latent
ignorable model can be identiﬁed.
When the missing data mechanism depends on more variables, an additional instrumental
variable is required to identify parameters. If the missing-data mechanism depends on not
only Y but also the treatment assignment Z, we can still identify the parameters in this
model when we have one additional covariate (X) that can aﬀect the outcome Y but does
not depend on the other variables D and Z in the study. This model is more general than the
ﬁrst missing-data model. Here (X,U) is being used as an instrumental variable for ﬁnding
the eﬀect of Y on R. In Section 3.2, we present the results under this more general model.
In Section 3.3, we extend our identiﬁability results to an discrete outcome with more than
two categories.
3.1 Identiﬁability without Covariate
We consider a CN mechanism which satisﬁes the following assumption:
Assumption 6: P{Ri(z)|Yi(z), Di(z), U = u} = P{Ri(z)|Yi(z)} for z = 0 and 1, and
P{Ri(1)|Yi(1) = y} = P{Ri(0)|Yi(0) = y}.
When Z is randomized, Assumption 6 implies ρyzu = ρyz′u′ for any z = z′ or u = u′.
Before studying parameter identiﬁability, we compared Assumption 6 with the LI as-
sumption. The LI assumption requires that potential outcomes and associated potential
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7nonresponse indicators are independent within each level of the latent compliance covariate
(Frangakis and Rubin, 1999), that is P{R(1)|U, Y (1)} = P{R(1)|U} and P{R(0)|U, Y (0)} =
P{R(0)|U}. The LI assumption means patients drop out because of their latent compliance
class. Yet Assumption 6 means that patients may drop out because of a worsen disease
condition, which is related to the outcome. For example, they may drop out when they feel
more terrible after taking the assigned drugs. In our study, Y measures the hospitalization of
a subject and the reason for missing Y of a subject may due only to her/his hospitalization
status. So whether patients drop out of the trial is determined by their outcomes, not by
their inherent and invariable nature. These two assumptions are so diﬀerent that a wrong
assumption will have a serious impact on estimation of CACE unless CACE is close to zero.
We will see this point in our simulations.
Next theorem shows that the parameters are all identiﬁable under Assumption 6. For the
case of simplicity, we denote ρy = ρyzu and δyzu = P (Y = y,R = 1|Z = z, U = u). Under
Assumption 6, the vector of parameters is θ = (ξ, ωa, ωn, θ10a, θ11n, θ11c, θ10c, ρ0, ρ1).
Theorem 1: If Y is not independent of Z given U or if Y is not independent of U
given Z, then under Assumptions 1-4 and Assumption 6, the vector of parameters, θ, is
identiﬁable.
We give a detailed proof of this theorem in Appendix. It is worthwhile to note that if Y is
independent of Z given U and is also independent of U given Z, we can not identify all the
parameters. However, from θ10a = θ11n = θ11c = θ10c, we can get CACE = θ11c − θ10c = 0,
which means the treatment has no causal eﬀect on the outcome.
After we have shown identiﬁability of θ, we can derive the moment and ML estimators
of θ. Let Nyrzd be the observed number of patients with Y = y,R = r, Z = z,D = d.
The observed data, Ny1zd (for y, z, d = 0, 1) and N+0zd (for z, d = 0, 1), can be consid-
ered as from a multinomial distribution with the corresponding cell probabilities, νy1zd and
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ν+0zd, where N+0zd =
∑
y Ny0zd denotes an observed frequency with y’s value missing,
νy1zd = P (Y = y,R = 1, Z = z,D = d) and ν+0zd = P (R = 0, Z = z,D = d).
Then the moment estimator of CACE is ̂CACEnocova =
δ̂11c−δ̂10c
ρ̂1
. And we can obtain that
̂CACEnocova has an asymptotically normal distribution using the central limit theorem
and the multivariate delta method. Since moment estimates may be the outside of the
parameter space in practice (Zhou and Li, 2006), we propose the EM algorithm to ﬁnd
ML estimates in this article. In Theorem 1 the complete-data likelihood function is given
as Lc(θ) = Π
N
i=1P (Zi)P (Ui)P (Di|Zi, Ui)P (Yi|Zi, Ui)P (Ri|Yi). In the E step, we take the
expectation of the complete-data, given the observed data and the previous parameter
estimate θ = θ(k), that is n
(k+1)
yrzu = E{nyrzu|observed− data,θ(k)}. In the M step, we can get
the ML estimates θ(k+1) from the n
(k+1)
yrzu .
3.2 Identiﬁability with a Covariate
In some clinical trials there are good reasons to believe that the missing data mechanism
is also aﬀected by the treatment assignment not just the outcome, because the occurrence
of side eﬀects diﬀers between treatment arms. In some clinical trials, a direct eﬀect of the
treatment assignment on the missing data mechanism is essentially implied by the study
design. For example, when patients in the treatment group experience severe side eﬀects, they
are removed from further study. Therefore, the response indicator of the outcome, R, depends
not only on the outcome Y itself but also other variables. The parameter vector θ is not
identiﬁable under only Assumptions 3, 4, and 6 without further assumptions. In this case, we
can introduce an additional covariate X which is observed before the assigned treatment, and
thus Z is independent of (X,U). Suppose that X associated with Y in each subpopulation of
U = u and Z = z (that is, P (y|x, z, u) = P (y|z, u) for some x and for all u and z) such that
the parameter vector θ becomes to be identiﬁable. For example, in some clinical trials it may
be reasonable to assume that the age of patients is associated with Y in each subpopulation.
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9Here we suppose that x is discrete. Then the following theorem shows that parameters are
identiﬁable. Let αxu = P (X = x, U = u), ρyzux = P (R = 1|Y = y, Z = z, U = u,X = x)
and θyzux = P (Y = y|Z = z, U = u,X = x). To emphasize the dependence of the causal
eﬀect parameter on covariates, we write CACE as CACEcova, which is deﬁned as follows:
CACEcova =
∑
x E{Y (1)−Y (0) | U = c,X = x}P (X = x|U = c) =
∑
x(θ11cx−θ10cx)αxc/ωc.
With availability of this covariate X, we can replace Assumption 6 by the following
assumption.
Assumption 7: For z = 0 and 1,
P{Ri(z)|Yi(z), Di(z), U = u,X = x} = P{Ri(z)|Yi(z)}. (1)
Assumption 7 means that the missing data mechanism depends on both the outcome Y and
the assigned treatment Z, which is weaker than Assumption 6. To identify parameters under
Assumption 7, we introduce an observed covariate X as an additional instrumental variable
in Theorem 2.
When the treatment assignment Z is randomized, we have from (1) that ρyzux = ρyzu′x′ for
any u = u′ or x = x′, and thus we can simply denote ρyzux as ρyz. The vector of parameters,
θ, is denoted as θ = (ξ, ωa, ωn, αxa, αxn, αxc, θ10ax, θ11nx, θ11cx, θ10cx, ρ00, ρ01, ρ10, ρ11).
Theorem 2: Suppose that X is an observed discrete covariate that depends on Y in
each subpopulation of U = u and Z = z. Then under Assumptions 1-4 and Assumption 7,
the vector of parameters, θ, is identiﬁable.
We give a proof of Theorem 2 in the appendix. Under the model in Theorem 2, we can obtain
the estimate of CACE aŝCACEcova1 =
∑
x(δ̂11cx/ρ̂11 − δ̂10cx/ρ̂10)α̂xc/ω̂c.
Note that in Theorems 1 and 2 we only make the exclusion restriction assumption, which
is weaker than the compound exclusion restriction assumption made in Frangakis and Rubin
(1999). If we also make the stronger compound exclusion assumption, we can further relax
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Assumption 7 to allow the missing-data mechanism to depend on both missing outcomes
and latent compliance status variable.
Assumption 8: For z = 0 and 1,
P{Ri(z)|Yi(z), Di(z), U = u,X = x} = P{Ri(z)|Yi(z), U = u}. (2)
This assumption assumes that the missing data mechanism depends on Y , Z and U .
When the treatment assignment Z is randomized, using (2) we obtain that ρyzux = ρyzux′
for any x = x′, and thus we can simply denote ρyzux as ρyzu. Since the compound exclusion
assumption (Assumption 5) holds, we have that ρy0n = ρy1n and ρy0a = ρy1a. Hence, the
vector of parameters, θ, is
θ = (ξ, ωa, ωn, αxa, αxn, αxc, θ10ax, θ11nx, θ11cx, θ10cx, ρ11n, ρ01n, ρ00a, ρ10a, ρ11c, ρ01c, ρ00c, ρ10c).
Theorem 3: Suppose that X is an observed discrete covariate that depends on Y in each
subpopulation of U = u and Z = z. Then under Assumptions 1-3, 5, and 8, the parameters
in θ are identiﬁable.
The diﬀerence between the models in Theorems 2 and 3 is in their missing data mechanisms.
For the model in Theorem 3, R depends on Y (Z), Z and U , while R depends only on Y (Z)
and Z in the model of Theorem 2. For the model of Theorem 3, we can obtain the estimate
of CACE aŝCACEcova2 =
∑
x(δ̂11cx/ρ̂11c − δ̂10cx/ρ̂10c)α̂xc/ω̂c.
3.3 Extension to multi-level outcomes
In this subsection we generalize Theorems 1, 2, and 3 to a multi-level outcome. Let Y be
a K-level discrete variable, where Y = 0, . . . , K − 1, and the covariate X be a J−valued
variable, i.e., X ∈ {0, 1, . . . , J − 1}. Since the proofs of corollaries are similar to theorems,
we omit the proofs for the sake of simplicity.
Corollary 1: If Y has fewer levels than 5, that is K < 5, and the rank of the 4 ×K
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matrix, ⎛
⎜⎜⎜⎜⎜⎜⎜⎜⎝
δ01n δ11n . . . δK−1,1n
δ00a δ10a . . . δK−1,0a
δ01c δ11c . . . δK−1,1c
δ00c δ10c . . . δK−1,0c
⎞
⎟⎟⎟⎟⎟⎟⎟⎟⎠
,
is equal to K, then the result of Theorem 1 holds.
Note if K > 4, the model of Theorem 1 cannot be identiﬁed without additional assumptions,
because the degree of freedom in the observed data is 4K + 3, which is smaller than the
number of parameters 5K − 1.
Corollary 2: Let us deﬁne the following J ×K matrices:
ΔMultizu =
⎛
⎜⎜⎜⎜⎜⎜⎜⎜⎝
δ0zu0 δ1zu0 . . . δK−1,zu0
δ0zu1 δ1zu1 . . . δK−1,zu1
...
... . . .
...
δ0zu,J−1 δ1zu,J−1 . . . δK−1,zu,J−1
⎞
⎟⎟⎟⎟⎟⎟⎟⎟⎠
(3)
where u = n, a, c and z = 0, 1.
(1) When J ≥ K, if the ranks of the two J ×K matrices, ΔMulti1n and ΔMulti0a , are equal to
K, then the result of Theorem 2 holds.
(2) When J ≥ K, if the ranks of the four J × K matrices, ΔMulti1n , ΔMulti1c , ΔMulti0a and
ΔMulti0c , are all equal to K, then the result of Theorem 3 holds.
4. Simulation Studies and Application
In our simulation studies, we ﬁrst assessed the relative performance of the moment and ML
estimators in ﬁnite-sample sizes when the assumptions were correct. We then assessed the
sensitivity of the derived moment and ML estimators when some of the assumptions were
violated.
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In the ﬁrst simulation study, we generated 1000 samples. Each of which had a sample
size of N = 500 under the model with a covariate as speciﬁed in Theorems 2. We computed
moment and ML estimates of parameters for every sample, their means, standard deviations,
and actual coverage percentages of 95% conﬁdence intervals. The result is reported in Table
1. We used the bootstrap to estimate the standard deviation. Since the moment and ML
estimates are all asymptotically normal distributions, we also computed conﬁdence intervals.
We also generated data under the missing-data models, given in Theorems 1 and 3. Since the
results were similar to that in Theorem 2, we only reported the results on the missing-data
model with a covariate in Theorem 2 for the sake of simplicity. From Table 1, we see that
except for ξ, ωn and ωa, the ML estimates perform better than the moments estimators.
In addition, for half of the samples the moment estimates are not proper (meaning that at
least one of the estimates for the sample is outside of the corresponding parameter’s range).
Hence we would recommend the ML estimates over the moment estimates.
[Table 1 about here.]
Next we conducted a sensitivity analysis of the proposed estimators between the LI as-
sumption and CN assumption. We assumed that the true model satisﬁed the CN assumption
described in Theorem 1, but we estimated the CACE under the wrong LI assumption.
Thus the true CACEtrue is θ11c − θ10c and the estimated CACEestimated is θ11cρ1θ11cρ1+(1−θ11c)ρ0 −
θ10cρ1
θ10cρ1+(1−θ10c)ρ0 . Let bias = |CACEestimated − CACEtrue|. We maximized bias over all values
from 0.0 to 1.0 by step 0.01 of θ11c, θ10c, ρ1 and ρ0. The result was reported in Figure 1. Each
curve in Figure 1 represents a ﬁxed CACE value, which was set to be 0.05, 0.1, 0.15, 0.2, and
0.25, respectively. For each of the ﬁve true CACEtrue values, we plotted a curve to represent
the relationship between the maximum bias of CACE estimates and a real parameter
|P (R = 1|Y = 1)−P (R = 1|Y = 0)| in Figure 1. Here, |P (R = 1|Y = 1)−P (R = 1|Y = 0)|
can be interpreted as a measure for the departure of the assumed LI model from the true CN
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model. The larger |P (R = 1|Y = 1)− P (R = 1|Y = 0)| is, the further away the assumed LI
model is from the true CN model. From Figure 1, we see that the further away the assumed
LI model is from the true CN mode, the bigger the bias of the CACE estimates obtained
under the wrong LI model is. From Figure 1, we can also see that the bias of estimated
CACE depends on the value of the true CACE. In general, the larger the true CACE is,
the bigger the bias of the estimated CACE is. As the true CACE decreases, the bias of
the estimated CACE also decreases, and as the CACE value tends to zero, the diﬀerence
between the estimates of the CACE under the CN and LI models also tends to zero.
[Figure 1 about here.]
[Figure 2 about here.]
In Figure 2, we assumed that the true missing-data mechanism model was the LI model, but
we used a wrong CN model to estimate the CACE. Thus the true CACEtrue is θ11c−θ10c and
the estimated CACEestimated is
(1−θ11n)γ1n−(1−θ10a)γ0a
γ1nγ0a(θ10a−θ11n) (θ11cγ1c − θ10cγ0c), where γzu = P (R =
1|Z = z, U = u). The bias is still denoted as bias = |CACEestimated − CACEtrue|. We
maximized bias over all values from 0.0 to 1.0 by step 0.01 of θ11c, θ10c, θ11n, θ10a, ρ1n, ρ0a,
ρ1c and ρ0c. We also found that the maximum bias of the estimated CACE was increasing
as the value of the true CACE was increasing. Thus, the estimate of CACE is sensitive to
the model of the missing data mechanism. The estimate of the CACE obtained from the LI
model is biased if the true missing-data mechanism is a CN model, and vice versa. On the
other hand, if the value of CACE tends to zero, the maximum bias tends to zero regardless
whether the true missing-data mechanism model is the CN model or the LI model. Here
the estimate of CACE under the assumption LI is given by Zhou and Li (2006), and the
estimate of CACE under the assumption CN is given by Theorem 1 in this paper.
We also compared our method with the method in which subjects with missing data
were discarded. We generated 1000 samples with sample size N = 3000 under the model
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of Theorem 1. In Table 2, we reported means and standard errors of estimates of CACE,
derived using our method and the method by discarding subjects with missing data. We ﬁx
ρ0 = 0.1 and change ρ1 from 0.2 to 0.9 and other parameters are ﬁxed as ξ = 0.5, ωn = 0.2,
ωa = 0.3, θ10a = 0.6, θ11n = 0.3, θ11c = 0.8 and θ10c = 0.2. From Table 2, we can see that
the bias of CACE estimates obtained by discarding subjects with missing data increases as
|ρ1 − ρ0| is increasing; whereas the estimates obtained by our method are very close to the
true CACE regardless of the value of |ρ1 − ρ0|.
[Table 2 about here.]
[Table 3 about here.]
Now we apply our method to ﬂu shot data, Zhou and Li (2006). We assume the CN missing-
data mechanism satisfying Assumption 6. The observed data are N1100 = 49, N0100 = 573,
N1101 = 16, N0101 = 143, N1110 = 47, N0110 = 499, N1111 = 20, N0111 = 256, N+000 = 492,
N+001 = 17, N+010 = 497, N+011 = 9. We report the results in Table 3. Since the moment
estimates are not proper, we only summarize the ML method. From the table, ρ̂0 = 1 and
the variance is equal to zero. This result means that all patients who were in hospital must
be observed.
The estimated CACE and its 95% conﬁdence interval are -0.1393 and (−0.4808, 0.2022)
respectively. For a comparison purpose, we listed the estimated CACE and its 95% conﬁdence
interval from Zhou and Li (2006) under the LN assumption. Under latent ignorability,
the estimated CACE is -0.009, and its associated 95% conﬁdence interval of CACE is (-
0.211,0.229). Both methods reached the same conclusion that inﬂuenza vaccination is not
associated with reduced risk of hospitalization for respiratory illness.
There are several limitations to the results of this application. First, we ignore clustering
eﬀect in the data that may lead to violation of the SUTVA assumption. Second, since
the study is not double blind, the exclusion restrictions assumption may be questionable,
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particularly among the always-takers, who are probably at high risk for ﬂu and then may
receive other medical actions beside ﬂu shots given by their physicians when their physicians
received a reminder about ﬂu shots.
5. Conclusion
In this paper we discussed the problem of non-compliance and non-ignorable missing outcome
mechanism. One major problem dealing with a non-ignorable missing data is the issue of
parameter identiﬁability. We gave suﬃcient conditions for identifying causal eﬀect parameters
under the CN missing-data mechanism, which is one type of non-ignorable missing and is
diﬀerent from the existing LI assumption. Under the CN missing-data mechanism, we give
a theorem on parameter identiﬁcation when the missing data mechanism depends only on
outcomes. With availability of a certain type of covariates, we can relax the missing data
mechanism assumption — Assumption 6 — to allow the missing-data mechanism to depend
on not only the missing outcome variable but also the treatment assignment Z and the
latent compliance status variable U . From the simulation results, the estimate of CACE is
sensitive to the missing data mechanism assumption. So we should pay attention to choose
the missing data mechanism in practice. It is still an open problem that how to test a non-
ignorable missing data mechanism. However, we can obtain from the simulations that the
CACE estimates is not sensitive to the missing data mechanism assumption as the true
CACE value tends to zero. Some assumptions in our theorems are (partly) testable from the
observed data, such as X is not associated with (D,Z).
Acknowledgements
We would like to thank referees for their valuable comments and suggestions that greatly
improved the presentation and structure of this paper. This work was supported in part by
Hosted by The Berkeley Electronic Press
16 Biometrics, 000 0000
NIH/NHLBI grant R01HL62567, NSFC, NBRP 2003CB715900 and IAD-06-088. It does not
necessarily represent the views of VA HSR&D Service.
References
Angrist, J. D., Imbens, G.W. and Rubin, D. B. (1996). Identiﬁcation of causal eﬀects using
instrumental variables (with Discussion). Journal of the American Statistical Association
91, 444-472.
Brown, C. H. (1990). Protecting Against Nonrandomly Missing Data in Longitudinal Studies.
Biometrics 46, 143-155.
Frangakis, C. E. and Rubin, D. B. (1999). Addressing complications of intention-to-treat
analysis in the combined presence of all-or-none treatment-noncompliance and subse-
quent missing outcomes. Biometrika 86, 365-379.
Imbenss, G. W. and Rubin, D. B. (1997). Bayesian inference for causal efects in randomized
experiments with noncompliance. The Annals of Statistics 25, 305-327.
Little, R. J. A. and Rubin, D. B. (2004). Statistical Analysis with Missing Data Second
Edition. John Wiley & Sons; New York, NY.
McDonald, C.J., Hui, S. L., and Tierney, W. M. (1992). Eﬀects of computer reminders for
inﬂuenza vaccination on morbidity during inﬂuenza epidemics. M. D. Computing 9, 304-
312.
O’Malley, A. J. and Normand, S-L. T. (2005). Likelihood Methods for Treatment Noncom-
pliance and Subsequent Nonresponse in randomized Trials. Biometrics 61, 325-334.
Robins, J. and Rotnitzky, A. (2004). Estimation of treatment eﬀects in randomized trials with
non-compliance and a dichotomous outcome using structural mean models. Biometrika
91, 763-783.
Vansteelandt, S. and Goetghebeur, E. (2005). Sense and sensitivity when correcting for
observed exposures in randomised clinical trials. Statistics in Medicine 24, 191-210.
http://biostats.bepress.com/uwbiostat/paper317
17
Yau, L. H. Y. and Little, R. J. (2001). Inference for the complier-average causal eﬀect from
longitudinal data subject to noncompliance and missing data, with application to a job
training assessment for the unemployed. Journal of the American Statistical Association
96, 1232-1244.
Zhou, X.H. and Li,S.M. (2006). ITT Analysis of Randomized Encouragement Design Studies
with Missing-Data. Statistics in Medicine 25, 2737-2761.
Appendix
Proof of Theorem 1:
Identiﬁability of ξ, ωa and ωn is immediate from randomization of Z and the monotonicity
assumption, that is, ξ = P (Z = 1), ωa = P (U = a) = P (D = 1|Z = 0) and ωn = P (U =
n) = P (D = 0|Z = 1). We next show that δyzu are the functions of the distributions of
observed variables. Under the Assumption 3, we obtain that δy1n = P (Y = y,R = 1|Z =
1, U = n) = P (Y =y,R=1,Z=1,D=0)
P (Z=1,D=0)
and that δy0a =
P (Y =y,R=1,Z=0,D=1)
P (Z=0,D=1)
.
For δy1c, we have δy1c =
P (Y =y,R=1,Z=1,U=c)
P (Z=1,U=c)
= P (Y =y,R=1,Z=1,D=1)−P (Y =y,R=1,D=1,Z=1,U=a)
P (Z=1,D=1)−P (D=1,Z=1,U=a) .
Under the monotonicity and randomization assumptions, P (D = 1, Z = 1, U = a) in the
denominator can be rewritten as P (Z = 1)P (D = 1, U = a|Z = 1) = P (Z = 1)P (U = a|Z =
1) = P (Z = 1)P (U = a|Z = 0) = P (Z = 1)P (D = 1, U = a|Z = 0) = P (Z = 1)P (D =
1|Z = 0). On the other hand, from the numerator we have that P (Y = y,R = 1, D = 1, Z =
1, U = a) = P (R = 1|Y = y,D = 1, Z = 1, U = a)P (Y = y|D = 1, Z = 1, U = a)P (D =
1, Z = 1, U = a), where P (R = 1|Y = y,D = 1, Z = 1, U = a) = P (R = 1|Y = y) = P (R =
1|Y = y,D = 1, Z = 0, U = a) because of Assumption 6, P (Y = y|D = 1, Z = 1, U = a) =
P (Y = y|D = 1, Z = 0, U = a) due to the exclusion restriction and P (D = 1, Z = 1, U =
a) = P (D = 1, U = a|Z = 0)P (Z = 1) by the forward proof. So P (Y = y,R = 1, D =
1, Z = 1, U = a) = P (R = 1|Y = y,D = 1, Z = 0, U = a)P (Y = y|D = 1, Z = 0, U =
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a)P (D = 1, U = a|Z = 0)P (Z = 1) = P (Y = y,R = 1, D = 1, U = a|Z = 0)P (Z = 1).
Hence, we obtain that δy1c =
P (Y =y,R=1,Z=1,D=1)−P (Y =y,R=1,D=1|Z=0)P (Z=1)
P (Z=1,D=1)−P (D=1|Z=0)P (Z=1) .
Similarly, we can show that δy0c =
P (Y =y,R=1,Z=0,D=0)−P (Y =y,R=1,D=0|Z=1)P (Z=0)
P (Z=0,D=0)−P (D=0|Z=1)P (Z=0) . Hence, we
have shown that δyzu’s are identiﬁable.
Next we will show that ρy’s are identiﬁable. Let us deﬁne the matrix Δ
1 as follows:
Δ1 =
⎛
⎜⎝ δ01n δ00a δ01c δ00c
δ11n δ10a δ11c δ10c
⎞
⎟⎠
T
.
Because θ0zu + θ1zu = 1 and from δyzu = ρyθyzu, we obtain the following equations:
Δ1
⎛
⎜⎝ 1/ρ0
1/ρ1
⎞
⎟⎠ = ( 1 1 1 1
)T
. (A.1)
Below we show that Δ1 has rank 2. Suppose that Δ1 does not have full column rank. Then
we have δ01n
δ11n
= δ00a
δ10a
= δ01c
δ11c
= δ00c
δ10c
, which implies θ01n
θ11n
= θ00a
θ10a
= θ01c
θ11c
= θ00c
θ10c
since δyzu = ρyθyzu.
Thus we obtain that θ10a = θ11n = θ11c = θ10c, which implies that Y is independent of Z
given U and is also independent of U given Z. This contradicts the condition of Theorem
1. Therefore, we have shown that ρy’s are identiﬁable. Finally, the parameters θyzu can be
identiﬁed from equations: θ10n = θ11n = δ11n/ρ1, θ11a = θ10a = δ10a/ρ1, θ11c = δ11c/ρ1 and
θ10c = δ10c/ρ1.
Proof of Theorem 2:
The joint distribution can be factorized as P (Z,U,D,X, Y,R) = P (R|Z,U,D,X, Y ) P (Y |Z,U,D,X)
P (D|Z,U,X)P (U,X|Z)P (Z). Since Z is randomized, P (U,X|Z) = P (U,X). Because D is
determined by (Z,U), we obtain that P (D|Z,U,X) = P (D|Z,U) and P (Y |Z,U,D,X) =
P (Y |Z,U,X). From the randomization assumption and Assumption 7, we obtain that
P (R|Z,U,D,X, Y ) = P (R|Y, Z). So we can rewrite the joint distribution as
P (Z,U,D,X, Y,R) = P (Z)P (U,X)P (D|Z,U)P (Y |Z,U,X)P (R|Y, Z).
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To identify P (U,X), we ﬁrst note that from independence of Z and (U,X), the deﬁnition of
U , and Assumption 3, we obtain that P (U = a|X = x) = P (U = a|Z = 0, X = x) = P (D =
1|Z = 0, X = x), P (U = n|X = x) = P (U = n|Z = 1, X = x) = P (D = 0|Z = 1, X = x)
and then P (U = c|X = x) = 1 − {P (U = n|X = x) + P (U = a|X = x)}. Since P (X)
is identiﬁable, P (U,X) is identiﬁable; since Z and U determine D, P (D|Z = z, U = u) is
known for all z and u.
Below we show that ρ01, ρ11, ρ00, ρ10, θ11nx, θ10ax, θ11cx and θ10cx are identiﬁable condition-
ally on X = x. Let us deﬁne the following matrices:
Δ2zu =
⎛
⎜⎝ δ0zux δ1zux
δ0zux′ δ1zux′
⎞
⎟⎠
Since
δyzux = P (R = 1|Y = y, Z = z)P (Y = y|Z = z, U = u,X = x) = ρyzθyzux, (A.2)
using the same idea as in the proof of Theorem 1, we obtain the following equations:
Δ21n
⎛
⎜⎝ 1/ρ01
1/ρ11
⎞
⎟⎠ =
⎛
⎜⎝ 1
1
⎞
⎟⎠ (A.3)
and
Δ20a
⎛
⎜⎝ 1/ρ00
1/ρ10
⎞
⎟⎠ =
⎛
⎜⎝ 1
1
⎞
⎟⎠ . (A.4)
Under Assumption 3, the elements in the matrices Δ21n and Δ
2
0a can be expressed by the
distributions of observed variables, respectively, as follows:
δy1nx =
P (Y = y,R = 1, Z = 1, D = 0, X = x)
P (Z = 1, D = 0, X = x)
(A.5)
and
δy0ax =
P (Y = y,R = 1, Z = 0, D = 1, X = x)
P (Z = 0, D = 1, X = x)
. (A.6)
Suppose that Δ21n in (A.3) is not full rank for all x = x′. Then it is immediate that Y is
independent of X given U = n and Z = z, which contradicts the assumptions in Theorem 2.
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Thus there exists at least one pair of x and x′ so that the matrix Δ21n is full rank, and then
ρ01 and ρ11 can be solved from (A.3). Similarly, we can show that ρ00 and ρ10 are identiﬁable
from (A.4).
From (A.2), (A.5) and (A.6), we can identify θy1nx and θy0ax. Similarly we can identify θy1cx
and θy0cx from the equations θy1cx =
δy1cx
ρy1
= P (y,R=1,Z=1,D=1,x)/(ξρy1)−P (y,R=1,Z=0,D=1,x)/{(1−ξ)ρy0}
P (Z=1,D=1,x)/ξ−P (D=1,Z=0,x)/(1−ξ)
and θy0cx =
P (y,R=1,Z=0,D=0,x)/{(1−ξ)ρy0}−P (y,R=1,Z=1,D=0,x)/(ξρy1)
P (Z=0,D=0,x)/(1−ξ)−P (D=0,Z=1,x)/ξ .
Proof of Theorem 3:
Similar to the proof of Theorem 2, we have P (Z,U,D,X, Y,R) = P (Z)P (U,X)P (D|Z,U)
P (Y |Z,U,X)P (R|Y, Z, U). Hence, we can identify δy1nx and δy0ax from (A.5) and (A.6) re-
spectively. We can also identify δy1cx and δy0cx by δy1cx =
P (y,R=1,Z=1,D=1,x)−P (y,R=1,D=1,Z=0,x)ξ/(1−ξ)
P (Z=1,D=1,x)−P (D=1,Z=0,x)P (Z=1)/P (Z=0)
and δy0cx =
P (y,R=1,Z=0,D=0,x)−P (y,R=1,D=0,Z=1,x)(1−ξ)/ξ
P (Z=0,D=0,x)−P (D=0,Z=1,x)P (Z=0)/P (Z=1) .
Next we show that we can identify ρyzu. We ﬁrst put δyzux’s into the following matrices:
Δ3zu =
⎛
⎜⎝ δ0zux δ1zux
δ0zux′ δ1zux′
⎞
⎟⎠ ,
for (z, u) = (1, n), (1, c), (0, a) and (0, c). Because R is independent of X given (Y, Z, U),
we obtain that δyzux = P (R = 1|Y = y, Z = z, U = u)P (Y = y|Z = z, U = u,X = x) =
ρyzuθyzux. Hence, we can obtain the following equations:
Δ3zu
⎛
⎜⎝ 1/ρ0zu
1/ρ1zu
⎞
⎟⎠ =
⎛
⎜⎝ 1
1
⎞
⎟⎠ .
Using the same argument as in the proof of Theorem 2, we can show that all fourΔ3zu matrices
have full ranks under the assumptions in Theorem 3. Therefore, we can identify ρyzu’s. Finally,
because δyzux = P (R = 1|Y = y, Z = z, U = u)P (Y = y|Z = z, U = u,X = x) = ρyzuθyzux,
we can identify θ10ax, θ11nx, θ11cx and θ10cx respectively.
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Figure 1. Real model: CN; Supposed model: LI.
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Figure 2. Real model: LI; Supposed model: CN.
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Table 1
Simulation results of comparison between moment method and ML method with covariate in Theorem 2, including
mean, standard deviation and actual 95% coverage probability. The level of covariate is 2 and N = 500.
Moment Method ML Method
Real Parameters Mean Std Dev 95%Cover Mean Std Dev 95%Cover
ξ = 0.5 0.4998 0.0225 0.950 0.4998 0.0225 0.950
P (U = n|X = 0) = 0.3 0.3003 0.0451 0.949 0.2993 0.0448 0.948
P (U = a|X = 0) = 0.2 0.2020 0.0422 0.954 0.2008 0.0419 0.947
P (U = n|X = 1) = 0.1 0.1007 0.0240 0.949 0.1001 0.0239 0.950
P (U = a|X = 1) = 0.5 0.5009 0.0397 0.949 0.4997 0.0393 0.949
P (X = 0) = 0.4 0.3997 0.0229 0.956 0.3997 0.0229 0.956
θ10a0 = 0.6 0.7124 0.3501 1.000 0.6201 0.2387 0.995
θ11n0 = 0.3 0.5013 0.3681 1.000 0.2967 0.1169 0.961
θ11c0 = 0.8 0.6835 0.4362 1.000 0.7673 0.1727 0.953
θ10c0 = 0.2 0.3617 0.3806 0.832 0.2398 0.1981 0.941
θ10a1 = 0.5 0.6372 0.3430 1.000 0.5236 0.1690 0.966
θ11n1 = 0.2 0.4067 0.3863 0.804 0.2014 0.1301 0.959
θ11c1 = 0.7 0.6224 0.4610 1.000 0.6429 0.2745 0.936
θ10c1 = 0.1 0.2005 0.2614 0.911 0.1194 0.1052 0.956
ρ00 = 0.2 0.2331 0.2756 0.916 0.2111 0.0507 0.950
ρ01 = 0.3 0.3357 0.2883 0.912 0.3062 0.0793 0.952
ρ10 = 0.6 0.4103 0.2760 0.876 0.6271 0.2145 0.999
ρ11 = 0.8 0.3515 0.3154 0.639 0.8288 0.1237 0.997
CACE = 0.6 0.3823 0.6703 0.922 0.5254 0.2928 0.933
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Table 2
Sensitivity analysis of CN and the method by ignoring incompletely observed subjects. Covariate X is binary and
N = 3000. The true value of CACE is 0.6.
CACE CACEignor
Value of ρ1 Mean Std Dev Mean Std Dev
ρ1 = 0.2 0.5923 0.0891 0.5621 0.0867
ρ1 = 0.3 0.5992 0.0795 0.5018 0.0715
ρ1 = 0.4 0.5977 0.0754 0.4474 0.0611
ρ1 = 0.5 0.6001 0.0695 0.3983 0.0547
ρ1 = 0.6 0.5987 0.0663 0.3595 0.0490
ρ1 = 0.7 0.5947 0.0636 0.3239 0.0455
ρ1 = 0.8 0.5965 0.0631 0.2998 0.0410
ρ1 = 0.9 0.6017 0.0545 0.2757 0.0376
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Table 3
ML estimates and SE of ﬂu shot data.
Parameters MLE Std Dev(Bootstrap) 95% CI
ξ 0.5065 0.0097 (0.4874, 0.5255)
ωn 0.7839 0.0108 (0.7627, 0.8051)
ωa 0.1348 0.0091 (0.1170, 0.1525)
θ10a 0.1757 0.0234 (0.1300, 0.2215)
θ11n 0.5216 0.0143 (0.4936, 0.5495)
θ11c 1.379e-016 0.0268 (0.0000, 0.0526)
θ10c 0.1393 0.1722 (0.0000, 0.4768)
ρ0 1.0000 0.0000 (1.0000, 1.0000)
ρ1 0.1151 0.0095 (0.0965, 0.1337)
CACE -0.1393 0.1743 (−0.4808, 0.2022)
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